Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 218-964-8 | CAS number: 2304-30-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1982
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 982
- Report date:
- 1982
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- Tetrabutylphosphonium chloride
- EC Number:
- 218-964-8
- EC Name:
- Tetrabutylphosphonium chloride
- Cas Number:
- 2304-30-5
- Molecular formula:
- C16H36P.Cl
- IUPAC Name:
- tetrabutylphosphanium chloride
- Test material form:
- other: waxy solid
- Details on test material:
- - Name of test material (as cited in study report): CYPHOS 443
Constituent 1
- Specific details on test material used for the study:
- Purity > 98%
Test animals
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Weight at study initiation: 2.3 - 3.2 kg
- Acclimation period: 14 days
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- other: Ethylene carbonate
- Remarks:
- The substance was tested both with and without vehicle.
- Details on dermal exposure:
- TEST SITE
- Area of exposure: no less than 10% of the body surface area was available for application
- Type of wrap if used: The trunk of each animal was wrapped with an impermeable plastic film of Saran Wrap
REMOVAL OF TEST SUBSTANCE
- Washing (if done): Yes
- Time after start of exposure: 24h
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2 ml/kg
- Concentration (if solution): 11.9 to 66.8% w/w
- Constant volume used: yes - Duration of exposure:
- 24h
- Doses:
- Tetrabutylphosphonium chloride with Ethylene carbonate: 159, 302, 506, 676, 862 and 1368 mg/kg
Pure Tetrabutylphosphonium chloride: 100, 200, 300 and 400 mg/kg - No. of animals per sex per dose:
- 4
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Animals were observed for any signs of systemic toxicity and/or death frequently during the day of administration and thereafter, at least twice a day for 14 days. Body weights were recorded just prior to dosing and again on day 7 and day 14.
- Necropsy of survivors performed: yes
- Other examinations performed: Gross necropsy and examination were performed on each animal, whether it died during the study or was killed at the end of the study. The brain with spinal cord, heart, each kidney, spleen, liver and lungs were weighed. - Statistics:
- Each LC50 was calculated according to the method of Litchfield and Wilcoxon. The results of the quantitative continuous variables, such as body weight and organ weight changes, were intercompared for the test groups versus the control group by analysis of variance and by a multiple range test. These analyses included all animals alive at the appropriate weighing time. When a significant F value in the analysis of variance was observed, the latter test was employed to determine which group (or groups) differed significantly from which other group (groups).
Results and discussion
Effect levelsopen allclose all
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 225 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: Pure substance
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 600 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: with EC as a vehicle
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 500 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: with EC as a vehicle
- Mortality:
- See tables below for details. Death was preceded by cyanosis and convulsion, and occurred within 24h of dosing.
- Clinical signs:
- other: Clinical signs of Bu4PCl toxicity included weight loss, ataxia, hypotonia (head and ear droop), and labored breathing. These signs persisted for 2-4 days in surviving males and for 1-9 days in surviving females.
- Gross pathology:
- The mean male kidney weight/body weight ratios for both kindeys of the 506 and 862 mg/kg test groups were significantly increased as compared to those of the 676, 1368 mg/kg test groups and the control group. The mean male brain with spinal cord weight/body weight ratio of the 862 mg/kg exposure group was significantly higher than those of the 506, 676, 1368 mg/kg test groups and the control group. The mean female brain with spinal cord weight/body weight ratios of the 505, 676 and 862 mg/kg test groups were significantly higher than those of the 158, 302 mg/kg test groups and the control group.
The other mean organ weights (absolute and organ wt/body wt ratios) of rabbits receiving applications of Bu4PCl were comparable to controls.
Any other information on results incl. tables
BU4PCl with EC | ||
Application in mg/kg | Number of dead/Number of dosed | |
Male | Female | |
159 | 0/4 | 0/4 |
302 | * | 0/4 |
506 | * | 2/4 |
676 | 3/4 | 4/4 |
862 | 3/4 | 4/4 |
1368 | 4/4 | * |
LD50 | 600 | 500 |
mg/kg | mg/kg |
* Dose not tested
Pure BU4PCl | |
Application in mg/kg | Number of dead/Number of dosed |
Male | |
100 | 0/5 |
200 | 0/5 |
300 | 3/5 |
400 | 5/5 |
LD50 | 600 |
mg/kg |
Applicant's summary and conclusion
- Interpretation of results:
- Category 3 based on GHS criteria
- Conclusions:
- The LD50 for acute dermal exposure with the ethylene carbonate vehicle was 500-600 mg/kg. However, the LD50 by acute dermal exposure of undiluted compound was 225 mg/kg.
- Executive summary:
The acute dermal toxicity of Tetrabutylphosphonium chloride was tested according to acceptable scientific standards. The product was tested in ethylene carbonate as a vehicle but also as the pure undiluted substance.
Tetrabutylphosphonium chloride was applied to the skin of 4 or 5 rabbits of each sex at 159, 302, 506, 676, 862 and 1368 mg/kg in the vehicle or at 100, 200, 300 and 400 mg/kg as a pure compound for 24 hours. Animals were subjected to daily observations and weekly determination of body weight. Necropsy was performed upon death or after terminal sacrifice at the end of the study period.
The LD50 for acute dermal exposure with the ethylene carbonate vehicle was 500 (female) -600 (male) mg/kg. However, the LD50 by acute dermal exposure of undiluted compound was 225 mg/kg (male).
Based on these results, Tetrabutylphosphonium chloride should be classified as Category 3 for acute dermal toxicity according to the CLP and the UN GHS.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.